Jimenez

Former Novartis chief Joseph Jimenez discusses breakthroughs in gene therapy, future of CRISPR in medicine

Editor's Note: Novartis CEO Joseph Jimenez retired in January after eight years in the top job at one of the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists